ViaCyte
San Diego, CA
- Cell Therapy for Type 1 Diabetes
Press
- ViaCyte Awarded New CIRM Grant to Develop PEC-Direct for High-Risk Type 1 Diabetes
- ViaCyte Announces the Publication of a Report on Macroencapsulated Stem Cell-Derived Insulin-Producing Cells and the Issuance of Three Patents
- ViaCyte Announces Highly Anticipated Encapsulation Clinical Trial Site Expansion into Canada
